Follow the 위더스제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 위더스제약 has logged 14 reports. The latest transaction was disclosed on 20 November 2024 (Purchase). Among the most active insiders: 권광영. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
14 of 14 declarations
Withus Pharmaceutical is a South Korean pharmaceutical company focused on the development and marketing of medications. It is listed on the XKRX.